Effects of vitamin e and zinc supplementation on antioxidants in beta thalassemia major patients

Iranian Journal of Pediatrics

Volumn 21, Issue 1, 2011, Pages 8-14

  Rashidi, Mohammadreza ^a   Aboomardani, Maryam ^b   Rafraf, Maryam ^c   Arefhosseini, Seyed Rafie ^b   Keshtkar, Abbasali ^d   Joshaghani, Hamidreza ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidants; Body mass index; Glutathione peroxidase; Superoxide dismutase; Vitamin e; Zinc

Indexed keywords

ALPHA TOCOPHEROL; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; ZINC;

ADULT; ALPHA TOCOPHEROL DEFICIENCY; ARTICLE; BODY MASS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; THALASSEMIA MAJOR; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

EID: 79952943033     PISSN: 10184406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Weatherall Dj. The Thalassemias: Disorders of Globine Synthesis. In: Alichtman M, Beutler E, Kipps TJ, et al. Williams Hematology,7th ed. New York: McGrow Hill, 2006; Pp: 633-666.
2. Kwiathowski J. Hemoglobinopathies. In: Lanzkowsky P. Pediatric Hematology and Onchology, 3rd ed. Amesterdam: Academic press. 2000; Pp:124-144.
3. The statistical report of the office of programming for the prevention of the Beta thalassemia major in Iran, The health and medical education and genetic office of the ministry of health and medical education, Iran, 2001; P: 28.
4. Scott MD. H2O2 injury in beta-thalassaemicerythrocytes: Protective role of catalase and the prooxidant effect of GSH. Free Radical Biol Med 2006;40(7):1264-72.
5. Kessab Chekir A, Laradi S, Ferchichi S, et al. Oxidant, antioxidant status and metabolic data in patients with beta thalassaemia. Clin Chem Acta 2003;338(1-2):79-86.
6. Chakraborty I, Mitra S, Gachhui R, et al. Non-haem iron-mediated oxidative stress in haemoglobin E beta-thalassaemia. Ann Acad Med Singapore 2010;39(1):13-6.
7. Dhawan V, Kumar Kh R, Marwaha RK, et al. Antioxidant status in children with homozygous thalassaemia. Indian Pediatr 2005;42(11):1141-5.
8. Chan AC, Chow CK, Chiu D. Interaction of antioxidants and their implication in genetic anemia. Proc Soc Biol Med 1999;222(3):274-82.
9. Michiels C, Raes M, Toussaint O, et al. Importance of Se-GPX, Catalase and Cu/Zn-SOD for cell survival against oxidative stress. Free Radical Biol Med 1994;17(3):235-48.
10. Tesoriere L, D'Apra, DAllegra M, et al. Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in betathalassaemia intermedia patients. Free Radic Res 2001;34(5):529-40.
11. Nasr MR, Ali S, Elgabry E. Antioxidant micronutrients in children with thalassaemia in Egypt. East Mediterr Health J 2002;8(4-5):490-5.
12. Das N, Das Chowdhury T, Chattopadhyay A, et al. Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E. Pol Pharmacol 2004;56(1)85-96.
13. Arcasoy A, Canata D, Sinav B, et al. Serum zinc levels and zinc binding capacity in thalassaemia. J Trace Elem Med Biol 2001;15(2-3):85 -7.
14. Firky SI, Saleh SA, Sarkis NN, et al. Study of nutritional status among thalassaemia patients in Damanhour medical national institute. J Egypt public Health Assoc 2003;78(1-2):73- 93.
15. Kajanachumpol S, Tatu T, Sasanakul W, et al. Zinc and copper status of thalassemic children. Southeast Asian J Trop Med Public Health 1997; 28(4):877-80.
16. Vatanavicharn S, Prigsulka P, Pringsulka P, et al. Zinc and copper status in beta- thalassemic/Hb-E disease and Hb-H disease. Acta Haematol 1982; 68(4):317-20.
17. Arcasoy A, Cavdar A, Cin S, et al. Effects of zinc supplementation on linear growth in betathalassaemia (a new approach). Am J Hematol 1987; 24(2):127-36.
18. Al-Samarrai AH, Adaay MH, Al-Tikriti KA, et al. Evaluation of some essential element levels in thalassaemia major patients in Mosul district, Iraq. Saudi Med J 2008; 29(1):94-7.
19. Moafi A, Mobaraki G, Taheri SS, et al. Zinc in thalassemic patients and its relation with depression. Biol Trace Elem Res 2008;123(1-3): 8-13.
20. Bekheirnia MR, Shamshirsaz AA, Kamgar M, et al. Serum zinc and its relation to bone mineral density in beta-thalassemic adolescents. Biol Trace Elem Res 2004;97(3):215-24.
21. Reily C. The nutritional trace metals, 2nd ed. India: Black Well Publication. 2006; Pp: 82-116.
22. Powell S.R. The antioxidant properties of zinc. J Nutr 2000;130(5S Suppl):1447s-1454s.
23. Al-Refaie FN, Wonke B, Wickens DG, et al. Zinc concentration in patients with iron overload receiving oral iron chelator 1,2-di methyl-3- hydroxypyridin-4-one or desferrioxamine. J Clin Pathology 1994;47(7):657-60.
24. Aydinhok Y, Coker C, Karacli K, et al. Urinary zinc excretion and zinc status of patients with beta thalassaemia major. Biol Trace Elem Res. 1999; 70(2):165-72.
25. Hoffbrand VA. Deferioprone therapy for transfusional iron overload. Best Pract Res Clin Haematol 2005;18(2):299-317.
26. Amani R, Saeidi S, Nazari Z, et al. Correlation between dietary zinc intakes and its serum levels with depression scales in young female students. Biol Trace Elem Res 2010;137(2):150-8.
27. Mahan LK, Escot-Stump S. Krause's Food and Nutrition Therapy. 12th ed. Philadelphia: Saunders. 2008; Appendix, P: 1235.
28. Livrea MA, Tesoriere L, Pintaudi AM, et al. Oxidative stress and antioxidant status in betathalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996;88(9): 3608-14.
29. Mehdizadeh M, Zamani G, Tabatabaee S. Zinc status in patients with major beta-thalassaemia. Pediatr Hematol Oncol 2008; 25(1):49-54.
30. Vaculin S, Franek M, Vejrazka M. Role of oxidative stress in animal model of visceral pain. Neurosci Lett 2010;477(2):82-5.
31. Şimşek F, Öztürk G, Kemahli S, et al. Oxidant and antioxidant status in beta thalassaemia major patients. J Ankara Univ Faculty Med 2005;58(1): 34-38.
32. Naithani R, Chandra J, Bhattacharjee J, et al. Peroxidative stress and antioxidant enzymes in children with beta-thalassaemia major. Pediatr Blood Cancer 2005;46(7):780-5.
33. Pfeifer WP, Degasperi GR, Almeida MT, et al. Vitamin E supplementation reduces oxidative stress in beta thalassaemia intermedia. Acta Haematol 2008;120(4):225-31.
34. Cheng ML, Ho HY, Tseng HC, et al. Antioxidant deficit and enhanced susceptibility to oxidative damage in individuals with different forms of alpha-thalassaemia. Br J Haematol 2005;128(1):119-27.
35. Fraga CG, Oteiza PI. Iron toxicity and antioxidant nutrients. Toxicology. 2002;180(1):23-32.
36. Bao B, Prasad AS, Beck FW, et al. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Transl Res 2008;152(2):67-80.
37. Sidhu P, Garg ML, Dhawan DK. Protective effects of zinc on oxidative stress enzymes in liver of protein deficient rats. Drug Chem Toxicol 2005; 28(2);211-30.
38. Meral A, Tuncel P, Sürmen-Gür E, et al. Lipid peroxidation and antioxidant status in betathalassaemia. Pediatr Hematol Oncol 2000;17(8):687-93.
39. Carpino A, Tarantino P, Rago V, et al. Antioxidant capacity in seminal plasma of transfusiondependent beta-thalassemic patients. Exp Clin Endocrinol Diabetes. 2004;112(3):131-4.
40. Dissayabutra T, Tosukhowong P, Seksan P. The benefits of vitamin C and vitamin E in children with beta-thalassaemia with high oxidative stress. J Med Assoc Thai 2005; 88 Suppl 4:S317-21.
41. De Sanctis V, Vullo C, Katz M, et al. Gonadal function in patients with beta-thalassaemia major. J Clin Pathol 1988; 41(2):133-7.